Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections

OBJECTIVES: To describe the pharmacokinetic/pharmacodynamic (PK/PD) modelling and microbiological data that were used to support the recent European approval of ceftaroline fosamil 600 mg q8h by 2 h intravenous (iv) infusion for patients with complicated skin and soft tissue infections (cSSTIs) caus...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Das, Shampa, Li, Jianguo, Iaconis, Joseph, Zhou, Diansong, Stone, Gregory G, Yan, Jean Li, Melnick, David
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6337900/
https://ncbi.nlm.nih.gov/pubmed/30380060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky439
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars